New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
CTI BioPharma Corp.
CTIC
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

1B

Biotechnology

9.10USD

Shape0.01 ( 0.06%)
Market Closed (as of Jun 23, 19:58 EDT)
favorite-chart

Relative Strenght

98
favorite-chart

Volume Buzz

-2%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

0%

Quote Panel

Shape
Updated April 22, 2025
1W % 1M % 3M % 1Y %

Key Metrics

Shape
  • Market Cap

    1.20B


  • Shares Outstanding

    131.88M


  • Share in Float

    99.89M


  • Dividende

    0


  • Earning Date

    No Data


  • Price Target

    9.095


  • Average Volume

    5.66M


  • Beta

    0.830633


  • Range

    4.01-9.1


  • Industry

    Biotechnology


  • Website

    https://www.ctibiopharma.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

CTIC

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

No Data Available

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

SVB Leerink

initialise

Previous: Not converted

2022-10-17

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.20

arrow
arrow

N/A

-0.20
vs -0.14

Q1.21

arrow
arrow

N/A

-0.23
vs -0.20

Q2.21

arrow
arrow

N/A

-0.21
vs -0.19

Q3.21

arrow
arrow

N/A

-0.26
vs -0.15

Q4.21

arrow
arrow

N/A

-0.39
vs -0.20

Q1.22

arrow
arrow

N/A

-0.37
vs -0.23

Q2.22

arrow
arrow

N/A

-0.21
vs -0.21

Q3.22

arrow
arrow

N/A

-0.13
vs -0.26

Q4.22

arrow
arrow

N/A

-0.14
vs -0.39

Q1.23

arrow
arrow

N/A

-0.10
vs -0.37

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.20

arrow
arrow

NA

NA  vs NA

Q1.21

arrow
arrow

NA

NA  vs NA

Q2.21

arrow
arrow

NA

NA  vs NA

Q3.21

arrow
arrow

NA

NA  vs NA

Q4.21

arrow
arrow

NA

NA  vs NA

Q1.22

arrow
arrow

NA

2.3M  vs NA

Q2.22

arrow
arrow

NA

12.3M  vs NA

Q3.22

arrow
arrow

NA

18.2M  vs NA

Q4.22

arrow
arrow

NA

21.1M  vs NA

Q1.23

arrow
arrow

+951%

24.1M  vs 2.3M

Return on EquityShape

status-upQoQ

Q2.21

arrow
arrow

-32%

-0.32
vs -0.65

Q3.21

arrow
arrow

-62%

-0.62
vs -0.32

Q4.21

arrow
arrow

-1014%

-10.14
vs -0.62

Q1.22

arrow
arrow

+133%

1.33
vs -10.14

Q2.22

arrow
arrow

+430%

4.3
vs 1.33

Q3.22

arrow
arrow

+93%

0.93
vs 4.3

Q4.22

arrow
arrow

+96%

0.96
vs 0.93

Q1.23

arrow
arrow

+86%

0.86
vs 0.96

Institutionnal OwnershipShape

status-upQoQ

Q3.21

arrow
arrow

56

56
vs 47

19%

Q4.21

arrow
arrow

64

64
vs 56

14%

Q1.22

arrow
arrow

94

94
vs 64

47%

Q2.22

arrow
arrow

121

121
vs 94

29%

Q3.22

arrow
arrow

138

138
vs 121

14%

Q4.22

arrow
arrow

155

155
vs 138

12%

Q1.23

arrow
arrow

143

143
vs 155

-8%

Q2.23

arrow
arrow

3

3
vs 143

-98%

Earnings Growth

Latest News